We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+14.13%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$24.4B
AUM Growth
+$627M
Cap. Flow
-$540M
Cap. Flow %
-2.21%
Top 10 Hldgs %
48.29%
Holding
168
New
24
Increased
37
Reduced
33
Closed
24

Top Buys

Rank Stock Value
1
ETHA
iShares Ethereum Trust ETF
ETHA
+$221M
2
WAB icon
Wabtec
WAB
+$177M
3
K
Kellanova
K
+$173M
4
NSC icon
Norfolk Southern
NSC
+$171M
5
EXEL icon
Exelixis
EXEL
+$139M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.53B
2
HES
Hess
HES
+$804M
3
IQV icon
IQVIA
IQV
+$530M
4
LBRDK icon
Liberty Broadband Class C
LBRDK
+$421M
5
ANSS
Ansys
ANSS
+$350M

Sector Composition

Rank Sector Weight
1 Healthcare 33.14%
2 Technology 11.51%
3 Financials 9.33%
4 Communication Services 4.99%
5 Industrials 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCRX icon
126
BioCryst Pharmaceuticals
BCRX
$2.4B
$182K ﹤0.01%
+24,000
New +$200K
PACB icon
127
Pacific Biosciences
PACB
$370M
$173K ﹤0.01%
135,000
– –
SLDPW icon
128
Solid Power Inc Warrant
SLDPW
$10.6M
$168K ﹤0.01%
405,316
– –
SNDX icon
129
Syndax Pharmaceuticals
SNDX
$1.82B
$154K ﹤0.01%
10,000
– –
BGLWW
130
Blue Gold Ltd Warrant
BGLWW
$736K
$137K ﹤0.01%
+300,000
New +$137K
ARDX icon
131
Ardelyx
ARDX
$997M
$127K ﹤0.01%
23,000
– –
DYN icon
132
Dyne Therapeutics
DYN
$4.9B
$127K ﹤0.01%
10,000
– –
FOLD
133
DELISTED
Amicus Therapeutics
FOLD
$126K ﹤0.01%
16,000
– –
EVH icon
134
Evolent Health
EVH
$447M
$118K ﹤0.01%
14,000
– –
ALT icon
135
Altimmune
ALT
$599M
$104K ﹤0.01%
27,600
– –
CCCC icon
136
C4 Therapeutics
CCCC
$412M
$62.2K ﹤0.01%
28,000
– –
ANNA
137
AleAnna Inc
ANNA
$105M
$61.8K ﹤0.01%
78,400
– –
GERN icon
138
Geron
GERN
$949M
$58.9K ﹤0.01%
43,000
– –
IOVA icon
139
Iovance Biotherapeutics
IOVA
$2.87B
$56.4K ﹤0.01%
26,000
– –
CGC
140
Canopy Growth
CGC
$410M
$43.8K ﹤0.01%
30,000
– –
RVMDW icon
141
Revolution Medicines Inc Warrant
RVMDW
$127M
$36K ﹤0.01%
120,085
– –
BYND icon
142
Beyond Meat
BYND
$277M
$35.9K ﹤0.01%
19,000
– –
NVNIW
143
Nvni Group Limited Warrants
NVNIW
$836K
$27K ﹤0.01%
375,000
– –
IRWD icon
144
Ironwood Pharmaceuticals
IRWD
$714M
$17K ﹤0.01%
13,000
– –
ABT icon
145
Abbott
ABT
$187B
– –
-136,000
Closed -$18.5M
AKRO
146
DELISTED
Akero Therapeutics
AKRO
– –
-4,000
Closed -$213K
AMED
147
DELISTED
Amedisys
AMED
– –
-575,000
Closed -$56.6M
ANSS
148
DELISTED
Ansys
ANSS
– –
-997,128
Closed -$350M
AZEK
149
DELISTED
The AZEK Co
AZEK
– –
-3,141,400
Closed -$171M
BDSX icon
150
Biodesix
BDSX
$248M
– –
-6,400
Closed -$36.1K
3 4 5
6
7

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Farallon Capital Management held 168 positions worth $24.4B, up 2.6% from $23.8B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Farallon Capital Management's Q3 2025 filing shows 24 new, 37 increased, 33 reduced and 24 closed positions. Its largest new stake was iShares Ethereum Trust ETF: 7,450,730 shares worth $235M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.53B.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q3 2025 buy was iShares Ethereum Trust ETF: 7,450,730 shares worth $235M.
  • Farallon Capital Management added most to Wabtec in Q3 2025, an estimated $177M increase.
  • Farallon Capital Management's biggest Q3 2025 reduction was IQVIA, cutting an estimated $530M.
  • Farallon Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q3 2025, selling an estimated $3.53B.
  • Farallon Capital Management's ten largest holdings make up 48% of its $24.4B portfolio in Q3 2025.
  • Farallon Capital Management opened 24 new positions and closed 24 in Q3 2025.
  • Farallon Capital Management's portfolio value rose 2.6% quarter-over-quarter to $24.4B.

Based on Farallon Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.